ASO Author Reflections: First Do No Harm-Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis.
Can YurttasAlfred KönigsrainerMarkus W LöfflerPublished in: Annals of surgical oncology (2021)